A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
Clinical trial NCT04540211 · COMPLETED
Trial details
- NCT number
- NCT04540211
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2023-02-13
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.